AT MULTITARGET THERAPEUTICS
Onegene Biotechnology is a company developing transformative therapeutics to
build a better tomorrow for patients with complex and chronic diseases.
Onegene Biotechnology’s UniStac platform is an innovative protein conjugation technology that can combine more than two proteins, which are independently produced, with high efficiency. Unlike existing DNA level fusion, it can produce therapeutic recombinant proteins by post-translational fusion, therefore, it is an optimal platform technology for multi-target production of complicated proteins with large molecular weights.MORE
We are rapidly developing long-acting multi-target assets that canMORE
provide prolonged holistic benefit to treat complex and multifactorial
diseases such as metabolic, immunological diseases and cancers.